Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
How is the In Vitro Diagnostic Packaging Market size predicted to change over the forecast window of 2026–2035?
The in vitro diagnostic packaging market size has demonstrated robust growth in recent years. This market is projected to expand from $10.04 billion in 2025 to $10.82 billion by 2026, achieving a compound annual growth rate (CAGR) of 7.8%. Historically, this growth has been fueled by factors such as the increasing embrace of in vitro diagnostic testing, the expansion of clinical laboratory facilities, a heightened need for precise disease diagnosis, the rise in global healthcare spending, and the accessibility of sophisticated packaging materials.
The in vitro diagnostic packaging market is projected to experience robust expansion over the coming years. Its value is anticipated to reach $14.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.6%. This anticipated growth during the forecast period is fueled by several factors, including the expanding adoption of point-of-care diagnostics, a heightened emphasis on sustainable medical packaging solutions, the broadening scope of molecular diagnostics testing, increasing capital expenditure in healthcare infrastructure, and a stronger focus on the safety and integrity of the supply chain. Key trends characterizing the forecast period encompass a growing need for sterile and contamination-resistant packaging, the increasing implementation of tamper-evident IVD packaging solutions, an uptick in the utilization of high-barrier plastic and glass materials, the wider availability of customized packaging for diagnostic kits, and a strengthened focus on designs that comply with regulatory standards.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24250&type=smp
Which Drivers Are Contributing To The Expansion Of The In Vitro Diagnostic Packaging Market?
The projected expansion of the in vitro diagnostic (IVD) packaging market is attributed to the growing incidence and prevalence of chronic diseases and infections. These refer to persistent health conditions or illnesses caused by pathogens that endure over time and often result in long-term medical complications. The surge in the occurrence and spread of chronic diseases and infections is largely due to increased exposure to pathogens, with lifestyle choices, particularly poor diet and lack of physical activity, playing a significant role. In vitro diagnostic (IVD) packaging addresses chronic diseases and infections by ensuring the secure, reliable, and efficient delivery of diagnostic tests, which facilitates early detection and timely treatment, ultimately enhancing patient outcomes and healthcare efficiency. For instance, in March 2025, data published by the UK Health Security Agency, a UK-based executive agency, revealed that in England, the UK Health Security Agency (UKHSA) reported 368 measles cases in 2023, representing a nearly sevenfold increase from the 53 cases reported in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Hence, the rising incidence and prevalence of chronic diseases and infections is a primary driver for the in vitro diagnostic packaging market.
What Segment Classifications Make Up The In Vitro Diagnostic Packaging Market?
The in vitro diagnostic packaging market covered in this report is segmented –
1) By Packaging Type: Primary Packaging, Secondary Packaging, Tertiary Packaging
2) By Product: Bottles And Vials, Tubes, Petri Dishes, Closures, Other Products
3) By Material Type: Plastic, Glass, Metal, Composite Materials
4) By Application Area: Biochemistry, Microbiology, Immunology, Molecular Diagnostics
5) By End User: Hospitals, Laboratories, Academic Institutes, Other End Users
Subsegments:
1) By Primary Packaging: Cartridges, Microplates, Sample Collection Containers, Reagent Reservoirs, Diagnostic Cassettes, Dropper Bottles
2) By Secondary Packaging: Folding Cartons, Paperboard Sleeves, Trays, Multi-Compartment Boxes, Label Sets, Instruction Leaflets
3) By Tertiary Packaging: Corrugated Shipping Boxes, Pallets, Insulated Shippers, Foam Inserts Or Cushioning, Tamper-Evident Seals, Bulk Transport Containers
Which Trends Are Shaping Activity Within The In Vitro Diagnostic Packaging Market?
Major companies in the in vitro diagnostic packaging market are prioritizing the development of innovative products, including sustainable IVD packaging solutions, to improve sustainability and lessen the environmental impact of diagnostic product packaging. A sustainable IVD packaging solution involves utilizing environmentally friendly materials and practices for packaging diagnostic products, with the goal of minimizing environmental impact while ensuring product safety and integrity. For example, in March 2025, Oxford Gene Technology IP Limited, a UK-based diagnostic genomic solutions provider, introduced new, ecologically sustainable packaging for its CytoCell product line. This inventive packaging incorporates biodegradable and recyclable materials, aligning with the industry’s increasing adoption of eco-friendly methods. The redesigned packaging not only supports a more sustainable approach to product disposal but also simplifies processes for laboratories through streamlined and accessible digital documentation. This move highlights the company’s dedication to reducing waste and enhancing operational efficiency across the clinical and diagnostic sectors.
Which Leading Companies Dominate The In Vitro Diagnostic Packaging Market Share?
Major companies operating in the in vitro diagnostic packaging market are Thermo Fisher Scientific Inc., Siemens Healthineers, Amcor plc, Corning Incorporated, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., ProAmpac, DiaSorin S.p.A., Stevanato Group S.p.A., Sarstedt AG & Co. KG, Greiner AG, Phillips Medisize, Scantibodies Laboratory Inc., Sanner GmbH, DWK Life Sciences, MML Diagnostics Packaging Inc., TCS Biosciences Ltd., Thousand Peak Glass Bottle Co. Ltd., Gerresheimer AG, SCHOTT AG, Berry Global Inc., West Pharmaceutical Services Inc., SGD Pharma, Nipro Corporation
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostic-packaging-global-market-report
Which Region Is Anticipated To See The Fastest Growth In The In Vitro Diagnostic Packaging Market?
North America was the largest region in the in vitro diagnostic packaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostic packaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized In Vitro Diagnostic Packaging Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24250&type=smp
Browse Through More Reports Similar to the Global In Vitro Diagnostic Packaging Market 2026, By The Business Research Company
In Vitro Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report
Pharmaceutical Packaging Testing Equipment Global Market Report 2026
Healthcare Packaging Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/healthcare-packaging-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
